Kineret anakinra regulatory update

FDA granted Orphan Drug designation for Swedish Orphan Biovitrum's Kineret anakinra to treat cryopyrin-associated periodic syndromes (CAPS). The IL-1 receptor antagonist is in Phase III testing for CA...